Janssen-Cilag Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
261 result(s) found, displaying 21 to 30
-
-
Prescription medicine registrationActive ingredients: macitentan, tadalafil.
-
Aug-2024Prescription medicine evaluationActive ingredient: guselkumab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ERLYAND apalutamide 240 mg film-coated tablet bottle.
-
Jul-2024Prescription medicine evaluationActive ingredient: macitentan.
-
Cancellation by sponsorRequested by Janssen-Cilag Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for STELARA ustekinumab 90 mg/ 1 mL solution for injection pre-filled pen (One-Press patient-controlled injector).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for STELARA ustekinumab 45 mg/ 0.5 mL solution for injection pre-filled pen (One-Press patient-controlled injector).
-
Australian Public Assessment Report (AusPAR)Tecvayli (teclistamab) has been provisionally approved for the treatment of relapsed or refractory multiple myeloma in adult patients.
-